Ninlaro 3 MG capsule 3S
Ended Awarded
- Contract number
- SPE2DB25FKC00
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,333
Award facts
- Contract value 100% obligated
- $16,333.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,333.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NINLARO 3 mg capsules on September 24, 2025, with an ultimate completion date of October 16, 2025. This non-set-aside contract represents a standard pharmaceutical procurement through the federal medical supply chain, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability in fulfilling federal medical procurement requirements across a broad spectrum of therapeutic domains. The company's track record with the Defense Logistics Agency encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies, all awarded through competitive processes with firm fixed-price structures. This delivery order for NINLARO, a multiple myeloma treatment, exemplifies the company's role as a critical vendor supporting military and veteran healthcare systems through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FKC00?
SPE2DB25FKC00 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKC00 worth?
The government has obligated $16,333 on SPE2DB25FKC00.
Is contract SPE2DB25FKC00 an order under another contract?
Yes. SPE2DB25FKC00 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKC00 competed?
The extent of competition for SPE2DB25FKC00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award